Tag
Sino Biopharmaceutical Limited
2 articles
Cipla Signs Exclusive HER2 ADC Licensing Agreement
Cipla enters exclusive licensing agreement with SBP Group for HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102) in India, South Africa and 5 other emerging markets.
Cipla will handle local clinic
Cipla Signs Exclusive HER2 ADC License with SBP
Cipla Limited enters exclusive licensing agreement with SBP Group's subsidiary for HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102).
Cipla gains exclusive rights to develop and commercialize the